Moderna Announces That its COVID-19 Vaccine Candidate is 94.5% Effective | Hybiz

US-based biotechnology firm Moderna Inc on Monday said its vaccine candidate has been found to be 94.5 percent effective in preventing COVID-19, based on Phase 3 trials.
This comes just a week after Pfizer Inc and BioNTech SE announced that their vaccine candidate was more than 90 percent effective in preventing COVID-19.
"...the independent, NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5 percent," the company said in a statement.
This study, known as the COVE study, enrolled more than 30,000 participants in the US, it added.
"This is a pivotal moment in the development of our COVID-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people around the world as possible," Moderna CEO Stephane Bancel said

#Moderna #StephaneBancel #PfizerInc #BioNTech #DataSafetyMonitoringBoard #DSMB #COVID19Vaccine

HyBiz Tv is India’s most watched Digital Business Channel with over One Million regular viewers. In the 10 years of its existence, HyBiz Tv has provided a platform for business houses to promote, project and propagate their products and services. Corporate videos, promotional videos, interviews, ad- films, events coverage, current relevant news, meaningful discussions on contemporary subjects have given the audience relevant content which has helped in the rapid growth of the viewership. Clients from both the Telugu states and across the country have reaped rich dividends by engaging HyBiz Tv and now this has spread all over the country..